Market Pulse
Daily · Sep 17, 2026 · data.go.kr + ECOS
KOSPI
6,715.41
-2.56 (-0.04%)
KOSDAQ
822.18
+6.20 (+0.76%)
KOSPI 200
1,058.27
-1.78 (-0.17%)
USD/KRW
1,382.20
128940KOSPI·Feb 06, 2026
First Korean pharma to translate the obesity theme into earnings
Mirae Asset Securities published a company analysis report on Hanmi Pharm. Co., Ltd. (128940) titled "First Korean pharma to translate the obesity theme into earnings".
Summary
Covers Hanmi Pharm. Co., Ltd. (128940).
Covered stock
More on 128940
Roche��s answer to Eli Lilly and Novo NordiskMirae Asset Securities · Aug 26, 2026Focus on Beijing Hanmi��s recovery and pipeline progressMirae Asset Securities · Jul 29, 2026Eli Lilly deal adds to pipeline valueMirae Asset Securities · Jun 04, 2026Sailing With LillyKB Securities · Jun 02, 2026Initiating Coverage: Core Business Recovery; Obesity, R&D NextKB Securities · May 27, 20262Q25 review: Revenue misses, OP beatsMirae Asset Securities · Jul 29, 2025Focus on potential recovery in quarterly earnings and June ADA eventMirae Asset Securities · Feb 05, 2025